1,321 research outputs found

    What is the new paradigm in product quality?

    Get PDF
    The current product quality paradigm is founded upon a customer-focused product development process, in which the functionality and behaviour of a product are designed to fulfil the needs of customers, and technological innovation is used to expand the capability and enhance the performance of the product. However, this view of product quality does not reflect the current practices of today's leading manufacturers, who now offer "total solutions" based upon an integrated package of products and services with well defined characteristics tailored to individual needs. Concepts such as globalisation, mass customisation, product branding, e-commerce, and sustainability suggest that a new product quality paradigm is evolving. This paper will discuss our current understanding of product quality issues and outline our vision of the new quality paradigm for product developers

    What is the new paradigm in product quality?

    Get PDF
    The current product quality paradigm is founded upon a customer-focused product development process, in which the functionality and behaviour of a product are designed to fulfil the needs of customers, and technological innovation is used to expand the capability and enhance the performance of the product. However, this view of product quality does not reflect the current practices of today's leading manufacturers, who now offer "total solutions" based upon an integrated package of products and services with well defined characteristics tailored to individual needs. Concepts such as globalisation, mass customisation, product branding, e-commerce, and sustainability suggest that a new product quality paradigm is evolving. This paper will discuss our current understanding of product quality issues and outline our vision of the new quality paradigm for product developers

    Galaxy And Mass Assembly (GAMA): curation and reanalysis of 16.6k redshifts in the G10/COSMOS region

    Get PDF
    We discuss the construction of the Galaxy And Mass Assembly (GAMA) 10h region (G10) using publicly available data in the Cosmic Evolution Survey region (COSMOS) in order to extend the GAMA survey to z ∼ 1 in a single deg2 field. In order to obtain the maximum number of high precision spectroscopic redshifts we re-reduce all archival zCOSMOS-bright data and use the GAMA automatic cross-correlation redshift fitting code autoz. We use all available redshift information (autoz, zCOSMOS-bright 10k, PRIMUS, VVDS, SDSS and photometric redshifts) to calculate robust best-fitting redshifts for all galaxies and visually inspect all 1D and 2D spectra to obtain 16 583 robust redshifts in the full COSMOS region. We then define the G10 region to be the central ∼1 deg2 of COSMOS, which has relatively high spectroscopic completeness, and encompasses the CHILES VLA region. We define a combined r < 23.0 mag and i < 22.0 mag G10 sample (selected to have the highest bijective overlap) with which to perform future analysis, containing 9861 sources with reliable high-precision VLT-VIMOS spectra. All tables, spectra and imaging are available at http://ict.icrar.org/cutout/G10

    Burden, duration and costs of hospital bed closures due to acute gastroenteritis in England per winter, 2010/11-2015/16.

    Get PDF
    BACKGROUND: Bed closures due to acute gastroenteritis put hospitals under pressure each winter. In England, the National Health Service (NHS) has monitored the winter situation for all acute trusts since 2010/11. AIM: To estimate the burden, duration and costs of hospital bed closures due to acute gastroenteritis in winter. METHODS: A retrospective analysis of routinely collected time-series data of bed closures due to diarrhoea and vomiting was conducted for the winters 2010/11 to 2015/16. Two key issues were addressed by imputing non-randomly missing values at provider level, and filtering observations to a range of dates recorded in all six winters. The lowest and highest values imputed were taken to represent the best- and worst-case scenarios. Bed-days were costed using NHS reference costs, and potential staff absence costs were based on previous studies. FINDINGS: In the best-to-worst case, a median of 88,000-113,000 beds were closed due to gastroenteritis each winter. Of these, 19.6-20.4% were unoccupied. On average, 80% of providers were affected, and had closed beds for a median of 15-21 days each winter. Hospital costs of closed beds were £5.7-£7.5 million, which increased to £6.9-£10.0 million when including staff absence costs due to illness. CONCLUSIONS: The median number of hospital beds closed due to acute gastroenteritis per winter was equivalent to all general and acute hospital beds in England being unavailable for a median of 0.88-1.12 days. Costs for hospitals are high but vary with closures each winter

    Galaxy And Mass Assembly (GAMA): growing up in a bad neighbourhood - how do low-mass galaxies become passive?

    Get PDF
    Both theoretical predictions and observations of the very nearby Universe suggest that low-mass galaxies (log10_{10}[M_{*}/M_{\odot}]<9.5) are likely to remain star-forming unless they are affected by their local environment. To test this premise, we compare and contrast the local environment of both passive and star-forming galaxies as a function of stellar mass, using the Galaxy and Mass Assembly survey. We find that passive fractions are higher in both interacting pair and group galaxies than the field at all stellar masses, and that this effect is most apparent in the lowest mass galaxies. We also find that essentially all passive log10_{10}[M_{*}/M_{\odot}]<8.5 galaxies are found in pair/group environments, suggesting that local interactions with a more massive neighbour cause them to cease forming new stars. We find that the effects of immediate environment (local galaxy-galaxy interactions) in forming passive systems increases with decreasing stellar mass, and highlight that this is potentially due to increasing interaction timescales giving sufficient time for the galaxy to become passive via starvation. We then present a simplistic model to test this premise, and show that given our speculative assumptions, it is consistent with our observed results.Comment: 20 pages, 12 figures, Accepted to MNRA

    Non-Parametric Cell-Based Photometric Proxies for Galaxy Morphology: Methodology and Application to the Morphologically-Defined Star Formation -- Stellar Mass Relation of Spiral Galaxies in the Local Universe

    No full text
    (Abridged) We present a non-parametric cell-based method of selecting highly pure and largely complete samples of spiral galaxies using photometric and structural parameters as provided by standard photometric pipelines and simple shape fitting algorithms, demonstrably superior to commonly used proxies. Furthermore, we find structural parameters derived using passbands longwards of the gg band and linked to older stellar populations, especially the stellar mass surface density μ\mu_* and the rr band effective radius rer_e, to perform at least equally well as parameters more traditionally linked to the identification of spirals by means of their young stellar populations. In particular the distinct bimodality in the parameter μ\mu_*, consistent with expectations of different evolutionary paths for spirals and ellipticals, represents an often overlooked yet powerful parameter in differentiating between spiral and non-spiral/elliptical galaxies. We investigate the intrinsic specific star-formation rate - stellar mass relation (ψM\psi_* - M_*) for a morphologically defined volume limited sample of local universe spiral galaxies, defined using the cell-based method with an appropriate parameter combination. The relation is found to be well described by ψM0.5\psi_* \propto M_*^{-0.5} over the range of 109.5MM1011M10^{9.5} M_{\odot} \le M_* \le 10^{11} M_{\odot} with a mean interquartile range of 0.40.4\,dex. This is somewhat steeper than previous determinations based on colour-selected samples of star-forming galaxies, primarily due to the inclusion in the sample of red quiescent disks

    Actual versus 'ideal' antibiotic prescribing for common conditions in English primary care

    Get PDF
    Previous work based on guidelines and expert opinion identified 'ideal' prescribing proportions-the overall proportion of consultations that should result in an antibiotic prescription-for common infectious conditions. Here, actual condition-specific prescribing proportions in primary care in England were compared with ideal prescribing proportions identified by experts. All recorded consultations for common infectious conditions (cough, bronchitis, exacerbations of asthma or chronic obstructive pulmonary disease, sore throat, rhinosinusitis, otitis media, lower respiratory tract infection, upper respiratory tract infection, influenza-like illness, urinary tract infection, impetigo, acne, gastroenteritis) for 2013-15 were extracted from The Health Improvement Network (THIN) database. The proportions of consultations resulting in an antibiotic prescription were established, concentrating on acute presentations in patients without relevant comorbidities. These actual prescribing proportions were then compared with previously established 'ideal' proportions by condition. For most conditions, substantially higher proportions of consultations resulted in an antibiotic prescription than was deemed appropriate according to expert opinion. An antibiotic was prescribed in 41% of all acute cough consultations when experts advocated 10%. For other conditions the proportions were: bronchitis (actual 82% versus ideal 13%); sore throat (actual 59% versus ideal 13%); rhinosinusitis (actual 88% versus ideal 11%); and acute otitis media in 2- to 18-year-olds (actual 92% versus ideal 17%). Substantial variation between practices was found. This work has identified substantial overprescribing of antibiotics in English primary care, and highlights conditions where this is most pronounced, particularly in respiratory tract conditions

    Galaxy And Mass Assembly (GAMA): a deeper view of the mass, metallicity and SFR relationships

    Get PDF
    A full appreciation of the role played by gas metallicity (Z), star formation rate (SFR) and stellar mass (M*) is fundamental to understanding how galaxies form and evolve. The connections between these three parameters at different redshifts significantly affect galaxy evolution, and thus provide important constraints for galaxy evolution models. Using data from the Sloan Digital Sky Survey–Data Release 7 (SDSS–DR7) and the Galaxy and Mass Assembly (GAMA) surveys, we study the relationships and dependences between SFR, Z and M*, as well as the Fundamental Plane for star-forming galaxies. We combine both surveys using volume-limited samples up to a redshift of z ≈ 0.36. The GAMA and SDSS surveys complement each other when analysing the relationships between SFR, M* and Z. We present evidence for SFR and metallicity evolution to z ∼ 0.2. We study the dependences between SFR, M*, Z and specific SFR (SSFR) on the M*–Z, M*–SFR, M*–SSFR, Z–SFR and Z–SSFR relations, finding strong correlations between all. Based on those dependences, we propose a simple model that allows us to explain the different behaviour observed between low- and high-mass galaxies. Finally, our analysis allows us to confirm the existence of a Fundamental Plane, for which M* = f(Z, SFR) in star-forming galaxies

    Explaining variation in antibiotic prescribing between general practices in the UK

    Get PDF
    Objectives:Primary care practices in England differ in antibiotic prescribing rates, and, anecdotally, prescribers justify high prescribing rates based on their individual case mix. The aim of this paper was to explore to what extent factors such as patient comorbidities explain this variation in antibiotic prescribing. Methods:Primary care consultation and prescribing data recorded in The Health Improvement Network (THIN) database in 2013 were used. Boosted regression trees (BRTs) and negative binomial regression (NBR) models were used to evaluate associations between predictors and antibiotic prescribing rates. The following variables were considered as potential predictors: various infection-related consultation rates, proportions of patients with comorbidities, proportion of patients with inhaled/systemic corticosteroids or immunosuppressive drugs, and demographic traits. Results:The median antibiotic prescribing rate was 65.6 (IQR 57.4-74.0) per 100 registered patients among 348 English practices. In the BRT model, consultation rates had the largest total relative influence on antibiotic prescribing rate (53.5%), followed by steroid and immunosuppressive drugs (31.6%) and comorbidities (12.2%). Only 21% of the deviance could be explained by an NBR model considering only comorbidities and age and gender, whereas 57% of the deviance could be explained by the model considering all variables. Conclusions:The majority of practice-level variation in antibiotic prescribing cannot be explained by variation in prevalence of comorbidities. Factors such as high consultation rates for respiratory tract infections and high prescribing rates for corticosteroids could explain much of the variation, and as such may be considered in determining a practice's potential to reduce prescribing
    corecore